UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 64

Sortiert nach

Neutrophil Extracellular Traps Induced by IL8 Promote Diffuse Large B-cell Lymphoma Progression via the TLR9 Signaling

Clinical cancer research, 2019-03, Vol.25 (6), p.1867-1879

2019

Link zum Volltext

Verfügbarkeit prüfen

Screening Optimal Candidates with Operable, Early-Stage Triple-Negative Breast Cancer Benefitting from Capecitabine Maintenance: A Post-Hoc Analysis of the SYSUCC-001 Study

Breast (Edinburgh), 2024-05, Vol.76, p.103740-103740, Article 103740

2024

Link zum Volltext

Verfügbarkeit prüfen

The efficacy of human epidermal growth factor receptor 2 (HER2) blockade switching mode in refractory patients with HER2-positive metastatic breast cancer: a phase II, multicenter, single-arm study (SYSUCC-005)

BMC cancer, 2022-03, Vol.22 (1), p.271-271, Article 271

2022

Link zum Volltext

Verfügbarkeit prüfen

High-dose tamoxifen in high-hormone-receptor-expressing advanced breast cancer patients: a phase II pilot study

Therapeutic advances in medical oncology, 2021, Vol.13, p.1758835921993436-1758835921993436

2021

Link zum Volltext

Verfügbarkeit prüfen

Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-Arm, Prospective Study

Cancer Research and Treatment, 2024, 56(2), , pp.513-521

2024

Link zum Volltext

Verfügbarkeit prüfen

Establishment and Validation of Prognostic Nomograms Based on Serum Copper Level for Patients With Early-Stage Triple-Negative Breast Cancer

Frontiers in cell and developmental biology, 2021-11, Vol.9, p.770115-770115

2021

Link zum Volltext

Verfügbarkeit prüfen

Consolidation Radiotherapy in Stage IE- IIE, Non-Bulky Primary Gastric Diffuse Large B-Cell Lymphoma with Post-Chemotherapy Complete Remission

PloS one, 2015-07, Vol.10 (7), p.e0133469-e0133469

2015

Link zum Volltext

Verfügbarkeit prüfen

The Iron-Inflammation Axis in Early-Stage Triple-Negative Breast Cancer

Frontiers in cell and developmental biology, 2022-02, Vol.10, p.784179-784179

2022

Link zum Volltext

Verfügbarkeit prüfen

A Novel Prognostic Model Based on the Serum Iron Level for Patients With Early-Stage Triple-Negative Breast Cancer

Frontiers in cell and developmental biology, 2021-11, Vol.9, p.777215-777215

2021

Link zum Volltext

Verfügbarkeit prüfen

What is the appropriate genetic testing criteria for breast cancer in the Chinese population?—Analysis of genetic and clinical features from a single cancer center database

Cancer medicine (Malden, MA), 2023-06, Vol.12 (12), p.13019-13030

2023

Link zum Volltext

Verfügbarkeit prüfen

NAD Induces Astrocyte Calcium Flux and Cell Death by ART2 and P2X7 Pathway

The American journal of pathology, 2012-09, Vol.181 (3), p.746-752

2012

Link zum Volltext

Verfügbarkeit prüfen

Safety, tolerability, and pharmacokinetics of BAT8001 in patients with HER2‐positive breast cancer: An open‐label, dose‐escalation, phase I study

Cancer communications (London, England), 2021-02, Vol.41 (2), p.171-182

2021

Link zum Volltext

Verfügbarkeit prüfen

High‐dose Methotrexate plus temozolomide with or without rituximab in patients with untreated primary central nervous system lymphoma: A retrospective study from China

Cancer medicine (Malden, MA), 2019-04, Vol.8 (4), p.1359-1367

2019

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of primary prophylaxis with PEG-rhG-CSF in early-stage breast cancer patients receiving chemotherapy in China

Zhōnghuá zhŏngliú zázhì, 2020-10, Vol.42 (10), p.861

2020

Link zum Volltext

Verfügbarkeit prüfen

Entropy-weighted reconstruction adversary and curriculum pseudo labeling for domain adaptation in semantic segmentation

Neurocomputing (Amsterdam), 2022-09, Vol.506, p.277-289

2022

Link zum Volltext

Verfügbarkeit prüfen

Combining Pixel-Level and Structure-Level Adaptation for Semantic Segmentation

Neural processing letters, 2023-12, Vol.55 (7), p.9669-9684

2023

Link zum Volltext

Verfügbarkeit prüfen

The ratio of hemoglobin to red cell distribution width as a novel prognostic parameter in esophageal squamous cell carcinoma: a retrospective study from southern China

Oncotarget, 2016-07, Vol.7 (27), p.42650-42660

2016

Link zum Volltext

Verfügbarkeit prüfen

The prognostic value of androgen receptor (AR) in HER2-enriched metastatic breast cancer

Endocrine-related cancer, 2020-04, Vol.27 (4), p.199-208

2020

Link zum Volltext

Verfügbarkeit prüfen

The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma

Disease markers, 2017-01, Vol.2017, p.6570808-9

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Moxifloxacin plus Treatment of Physician's Choice in Patients with Metastatic Breast Cancer

The oncologist (Dayton, Ohio), 2020-10, Vol.25 (10), p.e1439-e1445

2020

Link zum Volltext

Verfügbarkeit prüfen

Trastuzumab plus endocrine therapy or chemotherapy as first-line treatment for metastatic breast cancer with hormone receptor-positive and HER2-positive: The sysucc-002 randomized clinical trial

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.1003-1003

2021

Link zum Volltext

Verfügbarkeit prüfen

Albumin-to-Alkaline Phosphatase Ratio: A Novel Prognostic Index of Overall Survival in Cisplatin-based Chemotherapy-treated Patients with Metastatic Nasopharyngeal Carcinoma

Journal of Cancer, 2017-01, Vol.8 (5), p.809-815

2017

Link zum Volltext

Verfügbarkeit prüfen

The efficacy of human epidermal growth factor receptor 2

BMC cancer, 2022-03, Vol.22 (1)

2022

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of primary prophylaxis with pegfilgrastim in early-stage breast cancer patients receiving chemotherapy in China

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e18349-e18349

2019

Link zum Volltext

Verfügbarkeit prüfen

Systemic Therapy Combined with Locoregional Therapy Improved Survival in Oligometastatic Breast Cancer: A Single-Center Retrospective Cohort Study

Journal of oncology, 2022-09, Vol.2022, p.1-10

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(63)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(24)
Oncology
(16)
Humans
(15)
Physical Sciences
(12)
Female
(11)
Patients
(10)
Survival
(10)
Breast Cancer
(9)
Metastasis
(9)
Middle Aged
(8)
Technology
(8)
Male
(7)
Medical Prognosis
(7)
Prognosis
(7)
Retrospective Studies
(7)
Aged
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Cancer
(6)
China
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Neutrophil Extracellular Traps Induced by IL8 Promote Diffuse Large B-cell Lymphoma Progression via the TLR9 Signaling

Screening Optimal Candidates with Operable, Early-Stage Triple-Negative Breast Cancer Benefitting from Capecitabine Maintenance: A Post-Hoc Analysis of the SYSUCC-001 Study

The efficacy of human epidermal growth factor receptor 2 (HER2) blockade switching mode in refractory patients with HER2-positive metastatic breast cancer: a phase II, multicenter, single-arm study (SYSUCC-005)

High-dose tamoxifen in high-hormone-receptor-expressing advanced breast cancer patients: a phase II pilot study

Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-Arm, Prospective Study

Establishment and Validation of Prognostic Nomograms Based on Serum Copper Level for Patients With Early-Stage Triple-Negative Breast Cancer

Consolidation Radiotherapy in Stage IE- IIE, Non-Bulky Primary Gastric Diffuse Large B-Cell Lymphoma with Post-Chemotherapy Complete Remission

The Iron-Inflammation Axis in Early-Stage Triple-Negative Breast Cancer

A Novel Prognostic Model Based on the Serum Iron Level for Patients With Early-Stage Triple-Negative Breast Cancer

What is the appropriate genetic testing criteria for breast cancer in the Chinese population?—Analysis of genetic and clinical features from a single cancer center database

NAD Induces Astrocyte Calcium Flux and Cell Death by ART2 and P2X7 Pathway

Safety, tolerability, and pharmacokinetics of BAT8001 in patients with HER2‐positive breast cancer: An open‐label, dose‐escalation, phase I study

High‐dose Methotrexate plus temozolomide with or without rituximab in patients with untreated primary central nervous system lymphoma: A retrospective study from China

Cost-effectiveness of primary prophylaxis with PEG-rhG-CSF in early-stage breast cancer patients receiving chemotherapy in China

Entropy-weighted reconstruction adversary and curriculum pseudo labeling for domain adaptation in semantic segmentation

Combining Pixel-Level and Structure-Level Adaptation for Semantic Segmentation

The ratio of hemoglobin to red cell distribution width as a novel prognostic parameter in esophageal squamous cell carcinoma: a retrospective study from southern China

The prognostic value of androgen receptor (AR) in HER2-enriched metastatic breast cancer

The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma

Efficacy of Moxifloxacin plus Treatment of Physician's Choice in Patients with Metastatic Breast Cancer

Trastuzumab plus endocrine therapy or chemotherapy as first-line treatment for metastatic breast cancer with hormone receptor-positive and HER2-positive: The sysucc-002 randomized clinical trial

Albumin-to-Alkaline Phosphatase Ratio: A Novel Prognostic Index of Overall Survival in Cisplatin-based Chemotherapy-treated Patients with Metastatic Nasopharyngeal Carcinoma

The efficacy of human epidermal growth factor receptor 2

Cost-effectiveness of primary prophylaxis with pegfilgrastim in early-stage breast cancer patients receiving chemotherapy in China

Systemic Therapy Combined with Locoregional Therapy Improved Survival in Oligometastatic Breast Cancer: A Single-Center Retrospective Cohort Study

Suchergebnisse filtern